# Hummingbird Bioscience

Source: https://onco.cc/companies/hummingbird-bioscience/  
OnCo record `hummingbird-bioscience` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Hummingbird Bioscience is a Singapore biotech that uses computational biology to pick hard-to-reach antibody epitopes; its HER3 antibody HMBD-001 was developed with Cancer Research UK.

## Summary

Hummingbird Bioscience uses its Rational Antibody Discovery platform to design antibodies against epitopes that block receptor function. HMBD-001 binds the dimerisation interface of HER3 and prevents ligand-dependent and ligand-independent signalling; it entered the clinic with Cancer Research UK in advanced solid tumours including NRG1 fusion-positive cancers. Other programmes include the VISTA antibody HMBD-002 and antibody-drug conjugates.

## Fields

- Kind: Company
- Last checked: 2026-09-17
- Also known as: Hummingbird Bioscience Pte Ltd
- Tags: drug-maker
- HQ: Singapore
- Type: biotech
- Website: https://www.hummingbirdbioscience.com/

## Sources

- Official website: https://www.hummingbirdbioscience.com/

## Connected records

- drugs: [HMBD-001](https://onco.cc/drugs/hmbd-001/)

---
JSON: https://onco.cc/api/v1/entities/hummingbird-bioscience.json